Results 241 to 250 of about 9,980,709 (276)
Some of the next articles are maybe not open access.

Prospective Evaluation of Prostate Specific Antigen and Prostate Specific Antigen Density in the Detection of Carcinoma of the Prostate

The Journal of Urology, 1997
We evaluated prospectively the ethnic variations in prostate specific antigen (PSA) and prostate specific antigen density in the detection of carcinoma of the prostate.A total of 297 consecutive patients with an elevated serum PSA and/or abnormal digital rectal examination underwent transrectal ultrasound with lesion directed and systematic biopsy (6 ...
J C, Presti   +4 more
openaire   +2 more sources

Value of Prostate Specific Antigen Density and Percent Free Prostate Specific Antigen for Prostate Cancer Prognosis

Journal of Urology, 2012
Limited data exist on the relationship of percent free prostate specific antigen and prostate specific antigen density with prostate cancer prognosis. Therefore, we compared percent free prostate specific antigen and prostate specific antigen density with prostate specific antigen, Gleason sum and stage to predict prostate cancer prognosis in a large ...
Jonas, Busch   +8 more
openaire   +2 more sources

Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate

Urologic Oncology: Seminars and Original Investigations, 1995
Prostate specific antigen (PSA) has become an important method for early detection of prostate cancer. It has been suggested that prostate specific antigen density (PSAD) may be a more efficient test for early detection than PSA alone. A series of 327 men undergoing prostate biopsy were evaluated by PSA and PSAD.
E J, Mueller   +4 more
openaire   +2 more sources

Clinical Use of Prostate-Specific Antigen and Prostate-Specific Antigen Density in the Staging of Patients with Cancer of the Prostate

European Urology, 1996
To examine the efficacy of prostate-specific antigen (PSA) and prostate-specific antigen density (PSAD) in staging patients undergoing radical prostatectomy for clinically localized prostate cancer (CaP).Prostate gland volumes were estimated in patients with clinically localized CaP (n = 119) performing transrectal ultrasound and employing the prolate ...
J M, Wolff   +4 more
openaire   +2 more sources

Racial Differences in Prostate-Specific Antigen Levels and Prostate-Specific Antigen Densities in Patients With Prostate Cancer

American Journal of Clinical Oncology: Cancer Clinical Trials, 1999
To compare serum prostate-specific antigen (PSA) levels and PSA density (PSAD) among African American (AA), white, and Hispanic men with prostate cancer (PC) seen in an urban, equal-access urology clinic. Between January 1988 and January 1993, 1,105 men were screened for PC at Cook County Hospital in Chicago, Illinois.
Ibrahim Abdalla   +4 more
openaire   +2 more sources

An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density

World Journal of Urology, 1993
Prostate-specific antigen (PSA) is the most accurate serum marker for cancer of the prostate (CaP). However, its sensitivity and specificity are suboptimal, especially at values ranging between 4.1 and 10.0 ng/ml (monoclonal), because benign prostatic hypertrophy and hyperplasia (BPH) and CaP frequently coexist in this range.
M C, Benson   +3 more
openaire   +2 more sources

Prostate-Specific Antigen Density and Age-Specific Prostate-Specific Antigen Values: The Solution of Prostate Cancer Screening?

European Urology, 1995
The results of 225 systematic prostate biopsies from 1992 to 1993 were evaluated retrospectively. The parameters prostate-specific antigen (PSA) density and age-specific PSA values were compared with digital rectal examination, transrectal ultrasound, and PSA as single parameters and possible combinations.
R, Paul, J, Breul, R, Hartung
openaire   +2 more sources

Role of prostate-specific antigen density after applying age-specific prostate-specific antigen reference ranges

Urology, 1995
To determine the potential role of prostate-specific antigen (PSA) density (PSAD) in the early detection of prostate carcinoma if we apply age-specific PSA reference ranges (2.5 ng/mL or less for ages 40 to 49 years, 3.5 or less for ages 50 to 59, 4.5 or less for ages 60 to 69, and 6.5 or less for ages 70 to 79.We retrospectively reviewed 3234 cases ...
A W, Meshref   +9 more
openaire   +2 more sources

The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific Antigen

Journal of Urology, 1992
Prostate specific antigen (PSA) is an extremely valuable tumor marker. However, its use in detection is limited by its low positive and negative predictive values. The ability of serum PSA to distinguish between benign and malignant prostatic conditions is particularly poor in the intermediate range of 4.1 and 10 ng./ml. by the Hybritech assay. We used
M C, Benson   +4 more
openaire   +2 more sources

Significance of examination of prostate-specific antigen and prostate-specific antigen density in patients with prostatic hyperplasia and prostate cancer

International Urology and Nephrology, 1997
Authors investigated PSA concentration and preoperative prostate volume in 113 histologically proved BPH and 31 prostatic cancer patients. PSA concentration was measured with the Hybritech kit, the prostate volume by ultrasound with the help of an ellipse and calculated by computer. There was no correlation between the age of patients and volume of the
I, Romics, D, Frang, I, Bodrogi
openaire   +2 more sources

Home - About - Disclaimer - Privacy